Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Provan

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
European Journal of Haematology|June 7, 2022
Incidence of adult primary immune thrombocytopenia in England-An updateIndraraj Umesh Doobaree, Katherine Conway, Haroon Miah, et al.
Blood|October 24, 2008
Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic reviewRoberto Stasi, Ameet Sarpatwari, Jodi B Segal, et al.
Autoimmunity Reviews|November 8, 2024
Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)Qizhao Li, Geneviève Marcoux, Yuefen Hu, et al.
Advances in Therapy|October 27, 2021
Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune ThrombocytopeniaRicardo Viana, Denise D'Alessio, Laura Grant, et al.
Frontiers in Medicine|October 27, 2023
Concurrent coronary artery disease and immune thrombocytopenia: a systematic reviewAlaa Rahhal, Drew Provan, Khaled Shunnar, et al.
British Journal of Haematology|January 5, 2019
The prevention of glucocorticoid-induced osteoporosis in patients with immune thrombocytopenia receiving steroids: a British Society for Haematology Good Practice PaperQuentin A Hill, John D Grainger, Jecko Thachil, et al.
Haematologica|April 16, 2017
Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopeniaDouglas B Cines, Jeffrey Wasser, Francesco Rodeghiero, et al.
Lancet (London, England)|February 24, 2009
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trialJames B Bussel, Drew Provan, Tahir Shamsi, et al.
British Journal of Haematology|May 7, 2020
Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemicSue Pavord, Jecko Thachil, Beverley J Hunt, et al.
Blood Reviews|July 6, 2023
Primary and secondary immune thrombocytopenia (ITP): Time for a rethinkTomás José González-López, Drew Provan, Abelardo Bárez, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
European Journal of Haematology|June 7, 2022
Incidence of adult primary immune thrombocytopenia in England-An updateIndraraj Umesh Doobaree, Katherine Conway, Haroon Miah, et al.
Blood|October 24, 2008
Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic reviewRoberto Stasi, Ameet Sarpatwari, Jodi B Segal, et al.
Autoimmunity Reviews|November 8, 2024
Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)Qizhao Li, Geneviève Marcoux, Yuefen Hu, et al.
Advances in Therapy|October 27, 2021
Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune ThrombocytopeniaRicardo Viana, Denise D'Alessio, Laura Grant, et al.
Frontiers in Medicine|October 27, 2023
Concurrent coronary artery disease and immune thrombocytopenia: a systematic reviewAlaa Rahhal, Drew Provan, Khaled Shunnar, et al.
British Journal of Haematology|January 5, 2019
The prevention of glucocorticoid-induced osteoporosis in patients with immune thrombocytopenia receiving steroids: a British Society for Haematology Good Practice PaperQuentin A Hill, John D Grainger, Jecko Thachil, et al.
Haematologica|April 16, 2017
Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopeniaDouglas B Cines, Jeffrey Wasser, Francesco Rodeghiero, et al.
Lancet (London, England)|February 24, 2009
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trialJames B Bussel, Drew Provan, Tahir Shamsi, et al.
British Journal of Haematology|May 7, 2020
Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemicSue Pavord, Jecko Thachil, Beverley J Hunt, et al.
Blood Reviews|July 6, 2023
Primary and secondary immune thrombocytopenia (ITP): Time for a rethinkTomás José González-López, Drew Provan, Abelardo Bárez, et al.
Pageof 9